Helicobacter Pylori and Proton Pump Inhibitor

Asan Medical Center

Status: Completed

Conditions: Helicobacter Infections

Treatments: Drug: PPI (proton pump inhibitor)

Study type: Observational

Funder types: Other

Identifiers

NCT02449941

2014-0341

Details and patient eligibility

About

The purpose of this study is to know the distribution of HP in stomach before use of PPI, during use of PPI, and after stop of PPI.

Full description

Endoscopy and biopsy will be performed to investigate the distrubition of HP before, during, and after using PPI.

Enrollment: 30 patients

Sex: All

Ages: 19 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Patients who are indicated to endoscopic resection due to gastric neoplasm
2. Aged between 19 to 65 years
3. Informed consent

Exclusion criteria

1. Previous history of HP eradication
2. Previous history of PPI use within 6 months
3. No HP infection

Trial design

30 participants in 1 patient group

Helicobacter pylori(HP) positive

Description:

Participants who are diagnosed with Helicobacter Pylori infection through ESD(endoscopic submucosal dissection) will be treated with PPI (proton pump inhibitor).

Treatment:

Drug: PPI (proton pump inhibitor)